Ferrer, Ricard

Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.

Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine

Sepsis Diagnosis and TreatmentAbdominal Surgery and Complications

Cited by 6,621

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine

Sepsis Diagnosis and TreatmentAbdominal Surgery and Complications

Cited by 5,082

Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.

Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine

Sepsis Diagnosis and TreatmentAbdominal Surgery and Complications

Cited by 3,652

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.

Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine

Sepsis Diagnosis and TreatmentAbdominal Surgery and Complications

Cited by 2,935

Improvement in Process of Care and Outcome After a Multicenter Severe Sepsis Educational Program in Spain

Ferrer, R. (2008) · JAMA

Sepsis Diagnosis and TreatmentHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 741

Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021

Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine

Sepsis Diagnosis and TreatmentHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 513

Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.

Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009) · American Journal of Respiratory and Critical Care Medicine

Sepsis Diagnosis and TreatmentHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 433

Impact of source control in patients with severe sepsis and septic shock.

Martínez, M. L., Ferrer, R., Torrents, E., Guillamat-Prats, R., Gomà, G., Suárez, D., Álvarez-Rocha, L., Pozo Laderas, J. C., Martín-Loeches, I., Levy, M. M., et al. (2017) · Critical Care Medicine

Sepsis Diagnosis and TreatmentAbdominal Surgery and Complications

Cited by 192

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 192

Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026

Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine

Sepsis Diagnosis and TreatmentAntibiotics Pharmacokinetics and Efficacy

Cited by 117

Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: The multinational AID-ICU inception cohort study

Collet, M. O., Caballero, J., Sonneville, R., Bozza, F. A., Nydahl, P., Schandl, A., Wøien, H., Citerio, G., van den Boogaard, M., Hästbacka, J., et al. (2018) · Intensive Care Medicine

Intensive Care Unit Cognitive DisordersAnesthesia and Sedative Agents

Cited by 114

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Pappas, P. G., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., Mccarty, T., Thompson, G. R., et al. (2023) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 65

Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial—Protocol and statistical analysis plan

Meyhoff, T. S., Hjortrup, P. B., Møller, M. H., Wetterslev, J., Lange, T., Kjær, M. N., Jonsson, A. B., Hjortsø, C. J. S., Cronhjort, M., Laake, J. H., et al. (2019) · Acta Anaesthesiologica Scandinavica

Sepsis Diagnosis and TreatmentHemodynamic Monitoring and Therapy

Cited by 47

Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam

Los-Arcos, I., Len, O., Martín-Gómez, M. T., González-López, J. J., Saéz-Giménez, B., Deu, M., Nuvials, X., Ferrer, R., Román, A., & Gavaldà, J. (2019) · Infection

Burkholderia infections and melioidosisInfections and bacterial resistance

Cited by 24

147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

Pappas, P., Kullberg, B. J., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., McCarty, T. P., et al. (2020) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 17